Patients who were at elevated perioperative cardiac risk , receiving chronic beta-blockade , and scheduled for major non-cardiac surgery were recruited in a blinded ( participants , clinicians , outcome assessors ) placebo-controlled randomized trial at three Canadian hospitals .